Toll‐Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells

Autor: Yi Li, Peter Kanellakis, Anh Cao, Peter G. Tipping, Ban-Hock Toh, Tin Kyaw, Alex Bobik, Hamid Hosseini, Edgar Liu, Christopher Tay, Karlheinz Peter
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Mice
Knockout
ApoE

medicine.medical_treatment
Interleukin-1beta
Vascular Medicine
Mice
0302 clinical medicine
Vascular Disease
cytokine
Medicine
Toll‐like receptor 4/MyD88
Original Research
Mice
Knockout

B-Lymphocytes
Toll-like receptor
biology
Interleukin-18
medicine.anatomical_structure
Cytokine
Tumor necrosis factor alpha
Peritoneum
medicine.symptom
Cardiology and Cardiovascular Medicine
IgM
B-Lymphocyte Subsets
Inflammation
Diet
High-Fat

Real-Time Polymerase Chain Reaction
Proinflammatory cytokine
Transforming Growth Factor beta1
03 medical and health sciences
Phagocytosis
Vascular Biology
Animals
B cell
Tumor Necrosis Factor-alpha
business.industry
Transforming growth factor beta
Atherosclerosis
Toll-Like Receptor 2
Toll-Like Receptor 4
B1a cells
TLR2
030104 developmental biology
Immunoglobulin M
inflammation
Toll-Like Receptor 9
Myeloid Differentiation Factor 88
Immunology
biology.protein
Cancer research
business
030215 immunology
Zdroj: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ISSN: 2047-9980
DOI: 10.1161/jaha.115.002947
Popis: Background We previously identified peritoneal B1a cells that secrete natural IgM as a key atheroprotective B cell subset. However, the molecules that activate atheroprotective B1a cells are unknown. Here, we investigated whether Toll‐like receptors (TLRs) TLR 2, TLR 4, and TLR 9 expressed by B1a cells are required for IgM‐mediated atheroprotection. Methods and Results We adoptively transferred B1a cells from wild‐type mice or from mice deficient in TLR 2, TLR 4, TLR 9, or myeloid differentiation primary response 88 (MyD88) into ApoE −/− mice depleted of peritoneal B1a cells by splenectomy and fed a high‐fat diet for 8 weeks. Elevations in plasma total, anti‐oxLDL (oxidized low‐density lipoprotein), anti‐leukocyte, anti‐ CD 3, anti‐ CD 8, and anti‐ CD 4 IgMs in atherosclerotic mice required B1a cells expressing TLR 4 and MyD88, indicating a critical role for TLR 4‐MyD88 signaling for IgM secretion. Suppression of atherosclerosis was also critically dependent on B1a cells expressing TLR 4‐MyD88. Atherosclerosis suppression was associated not only with reductions in lesion apoptotic cells, necrotic cores, and ox LDL , but also with reduced lesion CD 4 + and CD 8 + T cells. Transforming growth factor beta 1 ( TGF ‐β1) expression, including macrophages expressing TGF ‐β1, was increased, consistent with increased IgM‐mediated phagocytosis of apoptotic cells by macrophages. Reductions in lesion inflammatory cytokines tumor necrosis factor alpha ( TNF ‐α), interleukin ( IL) 1β, and IL ‐18 were consistent with augmented TGF ‐β1 expression. Conclusions TLR 4‐MyD88 expression on B1a cells is critical for their IgM‐dependent atheroprotection that not only reduced lesion apoptotic cells and necrotic cores, but also decreased CD 4 and CD 8 T‐cell infiltrates and augmented TGF ‐β1 expression accompanied by reduced lesion inflammatory cytokines TNF ‐α, IL ‐1β, and IL ‐18.
Databáze: OpenAIRE